2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

[HTML][HTML] T2 mapping in myocardial disease: a comprehensive review

AT O'Brien, KE Gil, J Varghese, OP Simonetti… - Journal of …, 2022 - Elsevier
Cardiovascular magnetic resonance (CMR) is considered the gold standard imaging
modality for myocardial tissue characterization. Elevated transverse relaxation time (T2) is …

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

[HTML][HTML] SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance

T Leiner, J Bogaert, MG Friedrich, R Mohiaddin… - Journal of …, 2020 - Elsevier
Abstract The Society for Cardiovascular Magnetic Resonance (SCMR) last published its
comprehensive expert panel report of clinical indications for CMR in 2004. This new …

Cardiac sarcoidosis: state-of-the-art review

V Kouranos, R Sharma - Heart, 2021 - heart.bmj.com
Sarcoidosis is a systemic inflammatory disease characterised histologically by the formation
of non-caseating granuloma in multiple organs. 1 The cause of the disease remains …

[HTML][HTML] Cardiac sarcoidosis: diagnosis and management

E Markatis, A Afthinos, E Antonakis… - Reviews in …, 2020 - imrpress.com
Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Hybrid cardiac magnetic resonance/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis

S Greulich, S Gatidis, C Gräni, R Blankstein… - Cardiovascular …, 2022 - jacc.org
Objectives The purpose of this study was to investigate the diagnostic value of simultaneous
hybrid cardiac magnetic resonance (CMR) and 18F-fluorodeoxyglucose positron emission …

Myocardial fibrosis: why image, how to image and clinical implications

R Bing, MR Dweck - Heart, 2019 - heart.bmj.com
The current era has seen major advances in myocardial imaging. We are now able to
assess cardiac anatomy, function, tissue composition and disease activity across a wide …

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis

E Cheung, S Ahmad, M Aitken, R Chan… - European journal of …, 2021 - Springer
Purpose To evaluate the diagnostic and prognostic significance of combined cardiac 18F-
fluorodeoxyglucose (FDG) PET/MRI with T1/T2 mapping in the evaluation of suspected …

Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis

A Stevenson, JJH Bray, L Tregidgo, M Ahmad… - Cardiovascular …, 2023 - jacc.org
Background Sarcoidosis is a complex multisystem inflammatory disorder, with approximately
5% of patients having overt cardiac involvement. Patients with cardiac sarcoidosis are at an …